Marksans Pharma gets USFDA approval for Esomeprazole Magnesium delayed-release capsules
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
InvaGen has received 5 inspectional observations in Form 483
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Subscribe To Our Newsletter & Stay Updated